BiotechTube
Home/Sol-Gel Technologies/Alon Seri-Levy
AS

Alon Seri-Levy

Chief Executive Officer & Director

Sol-Gel Technologies

Therapeutic Areas

DermatologyAcneRosaceaPsoriasis

Sol-Gel Technologies Pipeline

DrugIndicationPhase
TWYNEO® (tretinoin/BPO)Acne vulgarisCommercial
EPSOLAY® (encapsulated BPO)Papulopustular RosaceaCommercial
SGT-210OnychomycosisPhase 2
SGT-310Facial Angiofibromas in TSCPhase 2
SGT-610Prurigo NodularisPhase 2
SGT-510Acne VulgarisPhase 2
SGT-710Seborrheic DermatitisPhase 2

Leadership Team at Sol-Gel Technologies

GM
Gilad Mamlok
Chief Financial Officer
MD
Marc D. Brown
Chief Scientific Officer
DT
David T. Tousley
Chief Commercial Officer
LF
Lior Finkelstein
Vice President, Operations
View full Sol-Gel Technologies profile